Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway.
Fabris L, Berton S, Citron F, D'Andrea S, Segatto I, Nicoloso MS, Massarut S, Armenia J, Zafarana G, Rossi S, Ivan C, Perin T, Vaidya JS, Avanzo M, Roncadin M, Schiappacassi M, Bristow RG, Calin G, Baldassarre G, Belletti B.
Fabris L, et al. Among authors: segatto i.
Oncogene. 2016 Sep 15;35(37):4914-26. doi: 10.1038/onc.2016.23. Epub 2016 Feb 15.
Oncogene. 2016.
PMID: 26876200
Free PMC article.